Our HTGF Portfolio of startups offers excellent opportunities and is always hiring talented people.
Verovaccines develops and markets a novel class of innovative, proprietary subunit marker vaccines for animal health. The technology provides a validated solution to the industry's need for cost-effective vaccines, reduced immunization effort, and reduced use of antibiotics. A recent development allows for the combination of several antigens (immunity generating substances) in a single vaccine without increasing production costs. This allows, for example, to target different pathogens with a single vaccine or to generate broad-band vaccines targeting immunity evading variants of the same pathogen. The company has a pipeline of five vaccine programs at various developmental stages. Four of these programs have already been validated (proof of concept). Several candidates have blockbuster potential. We are developing vaccine solutions for poultry, swine, and ruminants. Verovaccines is engaged in collaborations with market leaders as well as with academic institutions.
Something looks off?